Pursuant to subsection D of § 54.1-3443, the Board of Pharmacy is giving notice of a public hearing to consider placement of chemical substances in Schedule I of the Drug Control Act. The public hearing will be conducted at 9:01 a.m. on December 10, 2025. Instructions for public comment will be included in the agenda for the board meeting on December 10. Public comment may also be submitted electronically or in writing prior to December 10, 2025 to Caroline Juran, Executive Director of the Board of Pharmacy at caroline.juran@dhp.virginia.gov.

Pursuant to Virginia Code § 54.1-3443(D), The Virginia Department of Forensic Science (DFS) has identified two (2) compounds for recommended inclusion into the Code of Virginia.

Based on the chemical structure, the following compounds are expected to have depressant properties. Compounds of this type have been placed in Schedule I (Va. Code § 54.1-3446(4)) in previous legislative sessions.

1. 5-(2-chlorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one (other name: Methylclonazepam), its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. 
   
   
2. 8-bromo-1-ethyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (other name: Ethylbromazolam), its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.